First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions